Travere Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 1,180 | 0.0% | 30,877 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 610 | 0.0% | 25,533 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 381 | 0.0% | 25,728 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 411 | 0.0% | 22,956 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 348 | 0.0% | 19,969 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 279 | 0.0% | 19,969 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 136 | 0.0% | 16,511 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 127 | 0.0% | 16,511 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 148 | 0.0% | 16,511 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 148 | 0.0% | 16,511 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 192 | 0.0% | 12,504 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 277 | 0.0% | 12,311 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 198 | 0.0% | 9,432 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 185 | 0.0% | 7,504 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 182 | 0.0% | 7,504 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 249 | 0.0% | 9,673 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 332 | 0.0% | 10,686 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 186 | 0.0% | 7,680 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 112 | 0.0% | 7,676 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 189 | 0.0% | 7,587 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 211 | 0.0% | 7,734 | 12/31/2020 |